A Little Drama in Big Pharma: Remalda vs Laidlaw

Apparently, it takes a court order for enforce morality when the world of “big pharma” collides with the world of “shady finance”. Relmada Therapeutics has added an amendment to a previous Lawsuit against Laidlaw and its Principals, Matthew Eitner and James Ahern. Relmada Therapeutics is seeking damages and compensation as a result of Laidlaw’s efforts to spread “false information” in regards to Relmada. There is so much more to this.

The latest amendment to the lawsuit adds another installment in the accusations. Relmada Therapeutics claims Laidlaw disclosed sensitive and confidential financial information. How to handle classified and sensitive information has been a “hot-topic” in the USA lately. I am unsure if Hillary Clinton is to blame for this sensitive leak. In all seriousness, when did we lose our sense of care when guarding secrets in general?

There are two people you should trust in the this world: those that cook your food and those that handle your finances. Laidlaw has continually breached the trust of their clients over the years. It is beyond me that, it takes a team of lawyers and judges to re-teach the lessons of morality we learned in grammar school. My five year old can discern right from wrong better that Matthew Eitner and James Ahern. This is evident from the precedence that has been set since their inception as the principals of Laidlaw. Laidlaw is “laying” on a mattress made of lawsuits.

When the forces of evil decided to wipe each other out, I do nothing but watch in most cases. In this case, I truly believe Relmada Therapeutics is in the right and something needs to be done about Laidlaw. Something needs to be done about that type of “toxic leadership” poisoning some of our greatest business organizations.